Symbols / XAGE $0.31 +0.00% Longevity Health Holdings, Inc.

Consumer Defensive • Household & Personal Products • United States • OQB
XAGE Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Consumer Defensive
Industry Household & Personal Products
CEO Mr. Janakiram Ajjarapu
Exch · Country OQB · United States
Market Cap 767.35K
Enterprise Value 855.06K
Income -6.83M
Sales 1.79M
FCF (ttm) -513.09K
Book/sh -2.23
Cash/sh 0.13
Employees 10
Insider 10d —
IPO Sep 23, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 0.43
P/B -0.14
P/C —
EV/EBITDA -0.13
EV/Sales 0.48
Quick Ratio 0.04
Current Ratio 0.15
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -4.06
EPS next Y —
EPS Growth —
Revenue Growth -23.20%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -170.11%
ROE —
ROIC —
Gross Margin 67.69%
Oper. Margin -3.89%
Profit Margin 0.00%
Shs Outstand 2.48M
Shs Float 1.67M
Insider Own 36.10%
Instit Own 0.75%
Short Float 0.59%
Short Ratio 0.27
Short Interest 8.83K
52W High 8.27
vs 52W High -96.25%
52W Low 0.23
vs 52W Low 34.78%
Beta 0.38
Impl. Vol. —
Rel Volume 0.02
Avg Volume 2.81K
Volume 50.00
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.31
Price $0.31
Change 0.00%
About

Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.31
Latest analyst target
3. DCF / Fair value
$-3.73
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.31
Low
—
High
—
Mean
—
News
RSS: Latest XAGE news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-16 AJJARAPU J RAM Chief Executive Officer — 689,656 $0.40 $275,862
2024-09-13 UPTON RICHARD A. Director — 5,000 $0.47 $2,336
2024-09-10 CASSADAY BRYAN J Chief Financial Officer — 475 $0.46 $218
2024-09-06 FRISCH SCOTT M. Director — 1,009 $0.51 $515
2024-09-06 SPENLEHAUER GILLES Director — 1,009 $0.51 $515
2024-09-06 STURGEON PATRICK A Director — 1,261 $0.51 $643
2024-09-06 GREGORY KATHRYN Director — 1,260 $0.51 $643
2024-08-30 FRISCH SCOTT M. Director — 87 $0.57 $50
2024-08-30 SPENLEHAUER GILLES Director — 87 $0.57 $50
2024-08-30 STURGEON PATRICK A Director — 109 $0.57 $62
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1.91
+3701.44%
0.05
0.00
0.00
Operating Revenue
2.15
+2269.58%
0.09
0.00
0.00
Cost Of Revenue
0.82
+12768.51%
0.01
0.00
—
Reconciled Cost Of Revenue
0.68
+10623.17%
0.01
0.00
—
Gross Profit
1.09
+2390.30%
0.04
0.00
—
Operating Expense
8.20
+62.67%
5.04
-3.35%
5.22
-5.27%
5.51
Research And Development
0.79
-25.17%
1.05
-57.78%
2.50
+13.71%
2.20
Selling General And Administration
7.33
+87.85%
3.90
+48.87%
2.62
-18.47%
3.22
Selling And Marketing Expense
1.42
+651.65%
0.19
0.00
—
General And Administrative Expense
5.91
+59.12%
3.72
+41.65%
2.62
-18.47%
3.22
Other Gand A
5.91
+59.12%
3.72
+41.65%
2.62
-18.47%
3.22
Total Expenses
9.02
+78.66%
5.05
-3.23%
5.22
-5.27%
5.51
Operating Income
-7.11
-42.19%
-5.00
+4.19%
-5.22
+5.27%
-5.51
Total Operating Income As Reported
-7.11
-42.19%
-5.00
+15.90%
-5.94
-7.91%
-5.51
EBITDA
-6.64
+36.81%
-10.50
+30.87%
-15.19
-200.25%
-5.06
Normalized EBITDA
-6.72
-41.37%
-4.76
+5.32%
-5.02
+4.39%
-5.25
Reconciled Depreciation
0.22
+9.02%
0.20
+58.08%
0.12
-48.55%
0.24
EBIT
-6.85
+35.97%
-10.70
+30.15%
-15.32
-188.86%
-5.30
Total Unusual Items
0.09
+101.54%
-5.75
+43.50%
-10.17
-5324.92%
0.19
Total Unusual Items Excluding Goodwill
0.09
+101.54%
-5.75
+43.50%
-10.17
-5324.92%
0.19
Special Income Charges
0.09
+298.80%
-0.04
+93.86%
-0.73
+31.78%
-1.06
Other Special Charges
—
0.04
—
1.06
Restructuring And Mergern Acquisition
-0.15
0.00
-100.00%
0.73
0.00
Write Off
0.06
0.00
—
—
Net Income
-6.91
+33.40%
-10.37
+32.87%
-15.45
-70.64%
-9.05
Pretax Income
-6.87
+36.09%
-10.75
+33.68%
-16.21
-79.04%
-9.05
Net Non Operating Interest Income Expense
-0.02
+62.84%
-0.05
+94.49%
-0.89
+76.28%
-3.75
Interest Expense Non Operating
0.02
-62.84%
0.05
-94.49%
0.89
-76.28%
3.75
Net Interest Income
-0.02
+62.84%
-0.05
+94.49%
-0.89
+76.28%
-3.75
Interest Expense
0.02
-62.84%
0.05
-94.49%
0.89
-76.28%
3.75
Other Income Expense
0.26
+104.50%
-5.70
+43.55%
-10.10
-5013.78%
0.21
Other Non Operating Income Expenses
0.17
+275.34%
0.04
-34.86%
0.07
+529.66%
0.01
Gain On Sale Of Security
—
-5.70
+39.62%
-9.44
-849.72%
1.26
Tax Provision
0.04
+137.28%
-0.10
0.00
0.00
Tax Rate For Calcs
0.00
+2233.33%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.02
+135.99%
-0.05
0.00
0.00
Net Income Including Noncontrolling Interests
-6.91
+33.40%
-10.37
+32.87%
-15.45
-70.64%
-9.05
Net Income From Continuing Operation Net Minority Interest
-6.91
+35.16%
-10.65
+34.28%
-16.21
-79.04%
-9.05
Net Income From Continuing And Discontinued Operation
-6.91
+33.40%
-10.37
+32.87%
-15.45
-70.64%
-9.05
Net Income Continuous Operations
-6.91
+35.16%
-10.65
+34.28%
-16.21
-79.04%
-9.05
Net Income Discontinuous Operations
0.00
-100.00%
0.28
-62.88%
0.76
0.00
Normalized Income
-6.98
-40.71%
-4.96
+17.90%
-6.04
+34.70%
-9.25
Net Income Common Stockholders
-6.91
+33.40%
-10.37
+35.69%
-16.12
-67.79%
-9.61
Diluted EPS
-4.83
+66.83%
-14.56
+66.76%
-43.80
-192.31%
-14.98
Basic EPS
-4.83
+66.83%
-14.56
+66.76%
-43.80
-192.31%
-14.98
Basic Average Shares
1.43
+100.75%
0.71
+93.83%
0.37
-42.71%
0.64
Diluted Average Shares
1.43
+100.75%
0.71
+93.83%
0.37
-42.71%
0.64
Diluted NI Availto Com Stockholders
-6.91
+33.40%
-10.37
+35.69%
-16.12
-67.79%
-9.61
Amortization
0.08
-5.76%
0.08
-14.03%
0.10
—
Amortization Of Intangibles Income Statement
0.08
-5.76%
0.08
-14.03%
0.10
—
Depreciation Amortization Depletion Income Statement
0.08
-5.76%
0.08
-14.03%
0.10
+2.99%
0.09
Depreciation And Amortization In Income Statement
0.08
-5.76%
0.08
-14.03%
0.10
+2.99%
0.09
Preferred Stock Dividends
—
—
0.68
+21.48%
0.56
Total Other Finance Cost
—
—
—
2.04
Line Item Trend 2023-12-31
Total Assets
63.95
Current Assets
62.90
Cash Cash Equivalents And Short Term Investments
2.91
Cash And Cash Equivalents
2.91
Cash Financial
2.91
Receivables
0.20
Accounts Receivable
0.00
Taxes Receivable
0.20
Inventory
0.00
Prepaid Assets
0.76
Current Deferred Assets
0.00
Assets Held For Sale Current
53.32
Hedging Assets Current
5.70
Other Current Assets
—
Total Non Current Assets
1.05
Net PPE
1.02
Gross PPE
1.65
Accumulated Depreciation
-0.62
Properties
0.00
Machinery Furniture Equipment
0.00
Other Properties
1.53
Leases
0.12
Goodwill And Other Intangible Assets
0.02
Other Intangible Assets
0.02
Total Liabilities Net Minority Interest
39.20
Current Liabilities
38.50
Payables And Accrued Expenses
5.90
Payables
4.42
Accounts Payable
4.42
Other Payable
—
Current Accrued Expenses
1.48
Pensionand Other Post Retirement Benefit Plans Current
1.29
Total Tax Payable
—
Current Debt And Capital Lease Obligation
1.44
Current Debt
1.29
Other Current Borrowings
1.29
Current Capital Lease Obligation
0.15
Other Current Liabilities
29.87
Total Non Current Liabilities Net Minority Interest
0.70
Long Term Debt And Capital Lease Obligation
0.70
Long Term Debt
—
Long Term Capital Lease Obligation
0.70
Tradeand Other Payables Non Current
—
Preferred Securities Outside Stock Equity
0.00
Stockholders Equity
24.75
Common Stock Equity
24.75
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
0.77
Ordinary Shares Number
0.77
Treasury Shares Number
0.00
Additional Paid In Capital
83.25
Retained Earnings
-58.50
Total Equity Gross Minority Interest
24.75
Total Capitalization
24.75
Working Capital
24.40
Invested Capital
26.04
Total Debt
2.14
Net Debt
—
Capital Lease Obligations
0.85
Net Tangible Assets
24.72
Tangible Book Value
24.72
Derivative Product Liabilities
—
Interest Payable
1.18
Preferred Stock Equity
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-3.33
+14.49%
-3.89
+53.36%
-8.35
-143.48%
-3.43
Cash Flow From Continuing Operating Activities
-3.33
+14.49%
-3.89
+53.36%
-8.35
-143.48%
-3.43
Net Income From Continuing Operations
-6.91
+33.40%
-10.37
+32.87%
-15.45
-70.64%
-9.05
Depreciation Amortization Depletion
0.22
+9.02%
0.20
+58.08%
0.12
-48.55%
0.24
Depreciation
0.14
+19.87%
0.11
+311.11%
0.03
-88.37%
0.24
Amortization Cash Flow
0.08
-5.76%
0.08
-14.03%
0.10
+2050.42%
0.00
Depreciation And Amortization
0.22
+9.02%
0.20
+58.08%
0.12
-48.55%
0.24
Amortization Of Intangibles
0.08
-5.76%
0.08
-14.03%
0.10
+2050.42%
0.00
Other Non Cash Items
-0.15
+89.43%
-1.41
-595.57%
0.29
-89.02%
2.60
Stock Based Compensation
0.69
-16.23%
0.83
+23.87%
0.67
+4.92%
0.64
Asset Impairment Charge
0.06
0.00
—
—
Operating Gains Losses
—
5.70
-39.62%
9.44
+4951.69%
-0.19
Gain Loss On Investment Securities
—
5.70
-39.62%
9.44
+849.72%
-1.26
Change In Working Capital
2.76
+136.60%
1.17
+134.05%
-3.42
-246.34%
2.34
Change In Receivables
0.35
+441.30%
-0.10
+50.44%
-0.20
0.00
Changes In Account Receivables
0.04
+1177.91%
-0.00
0.00
—
Change In Inventory
0.37
+441.16%
-0.11
0.00
—
Change In Prepaid Assets
0.54
-43.96%
0.96
+245.40%
-0.66
-1098.36%
-0.06
Change In Payables And Accrued Expense
1.64
+200.12%
-1.64
-207.01%
-0.53
-120.99%
2.55
Change In Accrued Expense
1.52
+218.27%
-1.28
-378.13%
0.46
-69.00%
1.49
Change In Payable
0.13
+135.32%
-0.36
+63.92%
-1.00
-193.90%
1.06
Change In Account Payable
0.13
+135.32%
-0.36
+20.17%
-0.45
-142.44%
1.06
Change In Other Working Capital
—
—
—
-0.12
Change In Other Current Assets
0.00
-100.00%
4.66
-75.41%
18.97
+67416.87%
-0.03
Change In Other Current Liabilities
-0.14
+94.61%
-2.61
+87.58%
-20.99
-16713.38%
-0.12
Investing Cash Flow
-0.16
+78.07%
-0.75
-2357.49%
-0.03
-325.32%
-0.01
Cash Flow From Continuing Investing Activities
-0.16
+78.07%
-0.75
-2357.49%
-0.03
-325.32%
-0.01
Net PPE Purchase And Sale
-0.01
0.00
+100.00%
-0.03
-325.32%
-0.01
Purchase Of PPE
-0.01
0.00
+100.00%
-0.03
-325.32%
-0.01
Capital Expenditure
-0.01
—
-0.03
-325.32%
-0.01
Net Business Purchase And Sale
-0.15
+79.97%
-0.75
0.00
—
Purchase Of Business
-0.15
+79.97%
-0.75
0.00
—
Financing Cash Flow
4.04
+114.29%
1.89
-83.10%
11.16
+214.30%
3.55
Cash Flow From Continuing Financing Activities
4.04
+114.29%
1.89
-83.10%
11.16
+214.30%
3.55
Net Issuance Payments Of Debt
-0.44
+38.29%
-0.71
+46.77%
-1.34
-148.86%
2.75
Issuance Of Debt
—
0.50
-73.35%
1.86
-32.27%
2.75
Repayment Of Debt
-0.44
+38.29%
-0.71
+77.69%
-3.20
0.00
Long Term Debt Issuance
—
—
—
2.75
Net Long Term Debt Issuance
—
—
—
2.75
Short Term Debt Issuance
—
0.50
-73.35%
1.86
-32.27%
2.75
Short Term Debt Payments
-0.44
+38.29%
-0.71
+77.69%
-3.20
0.00
Net Short Term Debt Issuance
-0.44
+38.29%
-0.71
+46.77%
-1.34
-148.86%
2.75
Net Common Stock Issuance
3.48
+29.64%
2.69
0.00
+100.00%
-0.00
Common Stock Payments
—
—
0.00
+100.00%
-0.00
Repurchase Of Capital Stock
—
—
0.00
+100.00%
-0.00
Proceeds From Stock Option Exercised
1.00
0.00
-100.00%
0.04
-71.91%
0.15
Net Other Financing Charges
—
-0.09
-100.69%
12.46
+3196.14%
-0.40
Changes In Cash
0.55
+119.95%
-2.76
-198.96%
2.78
+2304.68%
0.12
Beginning Cash Position
0.16
-94.60%
2.91
+2172.71%
0.13
+936.64%
0.01
End Cash Position
0.71
+349.75%
0.16
-94.60%
2.91
+2172.71%
0.13
Free Cash Flow
-3.34
+14.12%
-3.89
+53.53%
-8.38
-143.86%
-3.44
Interest Paid Supplemental Data
0.02
-38.19%
0.03
-89.61%
0.28
+206.21%
0.09
Income Tax Paid Supplemental Data
—
0.00
-100.00%
0.75
0.00
Change In Income Tax Payable
—
0.00
+100.00%
-0.55
0.00
Change In Interest Payable
—
0.00
+100.00%
-0.11
-110.35%
1.06
Change In Tax Payable
—
0.00
+100.00%
-0.55
0.00
Common Stock Issuance
3.48
+29.64%
2.69
0.00
0.00
Issuance Of Capital Stock
3.48
+29.64%
2.69
0.00
-100.00%
1.06
Net Preferred Stock Issuance
—
—
0.00
-100.00%
1.06
Preferred Stock Issuance
—
—
0.00
-100.00%
1.06
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category